SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Israeli Treasury estimates deficit will deepen and stand at 4% at year’s end

Rafael to hire 2,000 amid surge in employees who want to ‘participate in war effort’

Eyes in the skies: NextVision’s founder pilots a new tech frontier

US fast-tracks $106.5 million tank shell sale to Israel

Buzz

Most popular

Daily

Weekly

1

Tuition of terror: Qatari money flowed into U.S. universities - and now it's fueling violence

2

Tech titans line up: The leading companies ready for blockbuster IPOs in 2024

3

Israel’s Tictuk acquired by Yum! Brands, owner of KFC, Pizza Hut, and Taco Bell

4

Fintech startup Pontera raises $60 million at $550 million valuation

5

The 50 most promising Israeli startups - 2023

Merck

4 stories about Merck

ד״ר צחון בנטואיץ׳ מייסד משותף של קיוריס Quris AI

Pharma giant Merck expands collaboration with Quris-AI

28.09.23|Meir Orbach

This follows the successful initial collaboration, a preclinical study to assess Quris-AI’s ability to predict drug toxicity in comparison to traditional in vitro and in vivo approaches

מוסף שבועי 18.5.23 פרופסור גל מרקל

Israeli biotech phenom puts death knell on cancer

21.05.23|Roni Dori

At 44, Gal Markel is a biotech bulldozer. After a $95 million exit, the professor of immunology serves as the Deputy Director General of Beilinson Hospital and the Director of the Davidoff Cancer Center, and is also involved in five startups. Now he has raised around $33 million to establish the Samueli Institute, researching ways to help the immune system eradicate cancer cells

“Pharma companies need to capitalize on early-stage breakthrough innovation.”

Collaboration is key for pharmaceutical companies as they seek to make the drug development process more efficient and successful, says Larisa Amir, managing director of Merck’s R&D Center.

Larisa Amir appointed Managing Director of Merck R&D Center in Israel

Amir will be responsible for managing the center and will also focus on in-house innovation and external scouting for technologies and biotechnology capabilities in Israeli startups, academia, and hospitals